Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period von Lee, M. K., Basch, E., Mitchell, S. A., Minasian, L. M., Langlais, B. T., Thanarajasingam, G., Ginos, B. F., Rogak, L. J., Mendoza, T. R., Bennett, A. V., Schrag, D., Mazza, G. L., Dueck, A. C.

Volltext

Optimizing Dosing of Oncology Drugs von Minasian, L, Rosen, O, Auclair, D, Rahman, A, Pazdur, R, Schilsky, R L

Volltext

A phase II study of durvalumab, a PD-L1 inhibitor and olaparib in recurrent ovarian cancer (OvCa) von Lee, J.-M., Annunziata, C.M., Houston, N., Kohn, E.C., Lipkowitz, S., Minasian, L., Nichols, E., Trepel, J., Trewhitt, K., Zia, F., Zimmer, A.D.S.

Volltext

Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions von Moon, D H, Lee, J-M, Noonan, A M, Annunziata, C M, Minasian, L, Houston, N, Hays, J L, Kohn, E C

Volltext

The generalizability of NCI-sponsored clinical trials accrual amongst women with gynecologic malignancies von Mishkin, G, Minasian, L, Kohn, E.C, Temkin, S.M

Volltext

Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE ® to Provide Two Distinct and Complementary Perspectives von Minasian, Lori M, O'Mara, Ann, Mitchell, Sandra A

Volltext

Postoperative complications and survivorship trends following ovarian cancer surgery in New York state von Xu, Z, Becerra, A.Z, Fleming, F.J, Boscoe, F.P, Schymura, M.J, Sinno, A.K, Morrow, G, Minasian, L, Temkin, S.M

Volltext

Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity von Lee, J-M, Sarosy, G A, Annunziata, C M, Azad, N, Minasian, L, Kotz, H, Squires, J, Houston, N, Kohn, E C

Volltext

Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter von Thompson, Ian M, Pauler, Donna K, Goodman, Phyllis J, Tangen, Catherine M, Lucia, M. Scott, Parnes, Howard L, Minasian, Lori M, Ford, Leslie G, Lippman, Scott M, Crawford, E. David, Crowley, John J, Coltman, Charles A

Volltext

Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials von REEVE, Bryce B, MITCHELL, Sandra A, CHAUHAN, Cynthia, AARONSON, Neil K, COENS, Corneel, BRUNER, Deborah Watkins, DUECK, Amylou C, BASCH, Ethan, CELLA, David, REILLY, Carolyn Miller, MINASIAN, Lori M, DENICOFF, Andrea M, O'MARA, Ann M, FISCH, Michael J

Volltext

Phase I/Ib study of the PARP inhibitor (PARPi) olaparib (O/AZD2281) in combination with carboplatin (C) in ovarian cancer (OvCa) patients with BRCA1/2 mutations (OvCaMUT +) and hig... von Hays, J, Noonan, A, Annunziata, C, Minasian, L, Zujewski, J, Houston, N, Hearn, J, Yu, M, Kohn, E

Volltext

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) von Basch, Ethan, Reeve, Bryce B, Mitchell, Sandra A, Clauser, Steven B, Minasian, Lori M, Dueck, Amylou C, Mendoza, Tito R, Hay, Jennifer, Atkinson, Thomas M, Abernethy, Amy P, Bruner, Deborah W, Cleeland, Charles S, Sloan, Jeff A, Chilukuri, Ram, Baumgartner, Paul, Denicoff, Andrea, St Germain, Diane, O'Mara, Ann M, Chen, Alice, Kelaghan, Joseph, Bennett, Antonia V, Sit, Laura, Rogak, Lauren, Barz, Allison, Paul, Diane B, Schrag, Deborah

Volltext

Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up von MINASIAN, L. M, MOTZER, R. J, GLUCK, L, MAZUMDAR, M, VLAMIS, V, KROWN, S. E

Volltext

Prevention and early detection of prostate cancer von Cuzick, Jack, Prof, Thorat, Mangesh A, MBBS, Andriole, Gerald, Prof, Brawley, Otis W, Prof, Brown, Powel H, Prof, Culig, Zoran, MD, Eeles, Rosalind A, Prof, Ford, Leslie G, MD, Hamdy, Freddie C, Prof, Holmberg, Lars, Prof, Ilic, Dragan, PhD, Key, Timothy J, Prof, Vecchia, Carlo La, Prof, Lilja, Hans, Prof, Marberger, Michael, Prof, Meyskens, Frank L, Prof, Minasian, Lori M, MD, Parker, Chris, MD, Parnes, Howard L, MD, Perner, Sven, Prof, Rittenhouse, Harry, PhD, Schalken, Jack, Prof, Schmid, Hans-Peter, Prof, Schmitz-Dräger, Bernd J, Prof, Schröder, Fritz H, Prof, Stenzl, Arnulf, Prof, Tombal, Bertrand, Prof, Wilt, Timothy J, Prof, Wolk, Alicja, Prof

Volltext

Earthquake rupture process recreated from a natural fault surface von Parsons, Tom, Minasian, Diane L.

Volltext

Implementation of PRO-CTCAE in phase I clinical trials identifies under reporting of adverse events von Veitch, Z.W., Shepshelovich, D., Gallagher, C., Wang, L., Razak, A.A., Spreafico, A., Bedard, P., Siu, L.L., Minasian, L., Hansen, A.R.

Volltext

1755PD - Implementation of PRO-CTCAE in phase I clinical trials identifies under reporting of adverse events von Veitch, Z.W., Shepshelovich, D., Gallagher, C., Wang, L., Razak, A.A., Spreafico, A., Bedard, P., Siu, L.L., Minasian, L., Hansen, A.R.

Volltext

1755PDImplementation of PRO-CTCAE in phase I clinical trials identifies under reporting of adverse events von Veitch, Z W, Shepshelovich, D, Gallagher, C, Wang, L, Razak, A A, Spreafico, A, Bedard, P, Siu, L L, Minasian, L, Hansen, A R

Volltext

Primary debulking surgery versus neoadjuvant chemotherapy in elderly patients with epithelial ovarian cancer von Xu, Z., Justiniano, C.F., Fleming, F.J., Boscoe, F.P., Schymura, M.J., Rubinsak, L.A., Morrow, G., Minasian, L., Temkin, S.M.

Volltext

Accrual to clinical trials: let's look at the physicians von Minasian, Lori M, O'Mara, Ann M

Volltext